IDEAYA Biosciences, Inc. (IDYA)
38.41
-0.20
(-0.52%)
USD |
NASDAQ |
Sep 18, 16:00
38.41
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Market Cap : 3.702B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.702B |
| September 17, 2026 | 3.721B |
| September 16, 2026 | 3.636B |
| September 15, 2026 | 3.630B |
| September 14, 2026 | 3.665B |
| September 11, 2026 | 3.623B |
| September 10, 2026 | 3.609B |
| September 09, 2026 | 3.696B |
| September 08, 2026 | 3.743B |
| September 04, 2026 | 3.842B |
| September 03, 2026 | 3.852B |
| September 02, 2026 | 3.871B |
| September 01, 2026 | 3.850B |
| August 31, 2026 | 3.865B |
| August 28, 2026 | 3.866B |
| August 27, 2026 | 4.026B |
| August 26, 2026 | 4.007B |
| August 25, 2026 | 4.094B |
| August 24, 2026 | 3.859B |
| August 21, 2026 | 3.823B |
| August 20, 2026 | 3.769B |
| August 19, 2026 | 3.746B |
| August 18, 2026 | 3.656B |
| August 17, 2026 | 3.522B |
| August 14, 2026 | 3.498B |
| Date | Value |
|---|---|
| August 13, 2026 | 3.535B |
| August 12, 2026 | 3.562B |
| August 11, 2026 | 3.550B |
| August 10, 2026 | 3.541B |
| August 07, 2026 | 3.568B |
| August 06, 2026 | 3.493B |
| August 05, 2026 | 3.166B |
| August 04, 2026 | 3.172B |
| August 03, 2026 | 3.110B |
| July 31, 2026 | 3.119B |
| July 30, 2026 | 3.198B |
| July 29, 2026 | 3.127B |
| July 28, 2026 | 3.177B |
| July 27, 2026 | 3.230B |
| July 24, 2026 | 3.110B |
| July 23, 2026 | 3.183B |
| July 22, 2026 | 3.075B |
| July 21, 2026 | 3.162B |
| July 20, 2026 | 3.115B |
| July 17, 2026 | 3.164B |
| July 16, 2026 | 3.157B |
| July 15, 2026 | 3.228B |
| July 14, 2026 | 3.220B |
| July 13, 2026 | 3.176B |
| July 10, 2026 | 3.250B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xencor, Inc. | 1.837B |
| UroGen Pharma Ltd. | 2.114B |
| MeiraGTx Holdings Plc | 1.248B |
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
Market Cap Related Metrics
| PS Ratio | 14.73 |
| Price to Book Value | 3.088 |
| Price | 38.41 |
| Earnings Yield | -5.06% |